Coronary heart disease secondary prevention smoking cessation
|
Coronary heart disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Coronary heart disease secondary prevention smoking cessation On the Web |
|
American Roentgen Ray Society Images of Coronary heart disease secondary prevention smoking cessation |
|
FDA on Coronary heart disease secondary prevention smoking cessation |
|
CDC on Coronary heart disease secondary prevention smoking cessation |
|
Coronary heart disease secondary prevention smoking cessation in the news |
|
Blogs on Coronary heart disease secondary prevention smoking cessation |
|
Risk calculators and risk factors for Coronary heart disease secondary prevention smoking cessation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Smoking Cessation
AHA / ACC 2012 Guidelines - Coronary Heart disease - Secondary Prevention for Patients With Coronary and Other Vascular Disease (DO NOT EDIT)[1]
Goal: Complete Cessation. No Exposure to environmental tobacco smoke.
| Class I |
| "1. Patients should be asked about tobacco use status at every office visit. (Level of Evidence: B) " |
| "2. Every tobacco user should be advised at every visit to quit. (Level of Evidence: A) " |
| "3. The tobacco user's willingness to quit should be assessed at every visit. (Level of Evidence: C) " |
| "4. Patients should be assisted by counseling and by development of a plan for quitting that may include pharmacotherapy and/or referral to a smoking cessation program. (Level of Evidence: A) " |
| "5. Arrangement for follow up is recommended. (Level of Evidence: C) " |
| "6. All patients should be advised at every office visit to avoid exposure to environmental tobacco smoke at work, home, and public places. (Level of Evidence: B) " |
References
- ↑ Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA; et al. (2011). "AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation". Circulation. 124 (22): 2458–73. doi:10.1161/CIR.0b013e318235eb4d. PMID 22052934.